This Women’s Health Week in Australia, MS Australia highlights the unique challenges faced by three women living with multiple sclerosis….

A phase 3 clinical trial of the BTK inhibitor, tolebrutinib, has shown a reduction in disability accumulation in people with…

MS Australia supports a proposal to allow nurse practitioners to prescribe key MS medications, improving access to care in underserved…

The Multiple Sclerosis Journal has published the next iteration of The Pathways to Cures Roadmap, which outlines research areas with…

CEO Rohan Greenland reflects on the 20th anniversary of MS Australia’s national MS research program, a program which has helped…

New study reveals key workplace factors linked to unemployment risk in people with MS….

Two-time Paralympian Emily Petricola and first-time Paralympian Ameera Lee share what it means to wear Green and Gold in the…

A new Australian study has found that lower doses of rituximab may be an effective and safe treatment for NMOSD….

Researchers develop new molecule to boost myelin repair in MS….

In November 2024, the Pharmaceutical Benefits Advisory Committee (PBAC) will meet to consider a proposal to recommend adding ravulizumab (Ultomiris®)…

Jen Willis, the first Australian with multiple sclerosis to attempt to summit Mount Everest, recently led a trek to Everest…

MS Australia CEO Rohan Greenland reflects on Chair Des Graham’s tenure in the wake of his retirement announcement and his…